Efficacy and Side Effects of Blacksoap® as Adjuvant Therapy of Scabies
Primary Purpose
Scabies
Status
Completed
Phase
Not Applicable
Locations
Indonesia
Study Type
Interventional
Intervention
Blacksoap(R)
Sponsored by
About this trial
This is an interventional treatment trial for Scabies
Eligibility Criteria
Inclusion Criteria:
- Students diagnosed with scabies and agreed to participate
- Age 12-18 years old
- Has been staying in the boarding school for at least 4 weeks
Exclusion Criteria:
- Not healthy (ie. fever or other conditions which caused subjects were not able to be examined)
- Secondary infection has been found ( yellow crusts, pus, dirty skin lesion, bullae, or systemic symptoms ie. fever)
Sites / Locations
- Departemen Dermatologi dan Venereologi Fakultas Kedokteran Universitas Indonesia
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Intervention
Control
Arm Description
Blacksoap(R) applied whole body twice daily
Johnson and Johnsons Baby Soap applied whole body twice daily
Outcomes
Primary Outcome Measures
Number of participants with scabies a week after first treatment
Number of participants with scabies a week after first treatment
Number of participants with scabies four weeks after second treatment
Number of participants with scabies four weeks after second treatment
Transepidermal water loss in gr/hr/m^2 on first week
Skin barrier damage one week after first treatment
Transepidermal water loss in gr/hr/m^2 on fourth week
Skin barrier damage one week after second treatment
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05025696
Brief Title
Efficacy and Side Effects of Blacksoap® as Adjuvant Therapy of Scabies
Official Title
Efficacy and Side Effects of Blacksoap® as Adjuvant Therapy of Scabies: a Single-blind Randomized Control Trial
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
September 18, 2018 (Actual)
Primary Completion Date
October 20, 2018 (Actual)
Study Completion Date
December 30, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Indonesia University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Background: Scabies is a skin disease due to Sarcoptes scabiei. The transmission risk is high among communities living together, such as dormitories, boarding schools, nursing homes, and so on. Blacksoap® is a soap product that is recognized as adjuvant therapy. Until now, there has been no research on the effectiveness and side effects of using Blacksoap®. Purpose: This research aimed to assess the cure rate of standard scabies treatment, with and without Blacksoap®, to determine pruritus visual analog scale (VAS) score, transepidermal water loss (TEWL) score before and after receiving therapy, and to evaluate the side effects of the treatment. Methods: The intervention group obtained standard therapy and Blacksoap®; meanwhile, the control group received standard therapy and baby soap.
Detailed Description
This study is a single-blind randomized clinical trial on scabies patient population at Pondok Pesantren Al Islami, Cibinong, Bogor. It is part of a research and social service by the Dermatology and Venereology Department of Faculty of Medicine Universitas Indonesia / dr. Cipto Mangunkusumo National Central General Hospital entitled "Early Detection of Scabies and Other Dermatoses and Evaluation of Scabies Treatment in Al-Hidayah and Al Islami Islamic Boarding School" Research subjects who are participating are those diagnosed with scabies (fulfilling 2 out of 4 cardinal signs of scabies).
The research was conducted from September to October 2018 with the entire scabies patient in Indonesia as the target population, and all students at Al Islami Boarding School who at the time had scabies as the accessible population. A random cluster sampling was done on the population member diagnosed with scabies based on the boarding school building location into the intervention group and control group. The intervention group was receiving permethrin 5% cream and Blacksoap®, while the control group was receiving permethrin 5% cream and baby soap.
Skin scraping examination was done on the research subjects with potassium hydroxide (KOH) solution to find the mites, alongside pruritus visual analog scale (VAS) score assessment and transepidermal water loss (TEWL) measurement before suitable therapy given. In the first and fourth weeks after the initial assessment, which includes the scabies cure rate, pruritus VAS score, TEWL score, and side effects evaluation, a follow-up was conducted. TEWL was measured using Tewameter® TM 300 made by Courage-Khazaka from Germany. Subsequent data were documented and processed using Statistical Product and Service Product (SPSS) program version 20. Finally, an analysis was done by a third-party which did not seem aware of the treatment given (single-blind).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Scabies
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A random cluster sampling was done on the population member diagnosed with scabies based on the boarding school building location into the intervention group and control group. The intervention group was receiving permethrin 5% cream and Blacksoap®, while the control group was receiving permethrin 5% cream and baby soap.
Masking
Investigator
Masking Description
The investigators who scraped the skin and did the transepidermal water loss examination were blinded on which arm the subjects were allocated.
Allocation
Randomized
Enrollment
78 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Blacksoap(R) applied whole body twice daily
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
Johnson and Johnsons Baby Soap applied whole body twice daily
Intervention Type
Other
Intervention Name(s)
Blacksoap(R)
Intervention Description
Blacksoap(R)
Primary Outcome Measure Information:
Title
Number of participants with scabies a week after first treatment
Description
Number of participants with scabies a week after first treatment
Time Frame
One week
Title
Number of participants with scabies four weeks after second treatment
Description
Number of participants with scabies four weeks after second treatment
Time Frame
Four weeks
Title
Transepidermal water loss in gr/hr/m^2 on first week
Description
Skin barrier damage one week after first treatment
Time Frame
One week
Title
Transepidermal water loss in gr/hr/m^2 on fourth week
Description
Skin barrier damage one week after second treatment
Time Frame
Four weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Students diagnosed with scabies and agreed to participate
Age 12-18 years old
Has been staying in the boarding school for at least 4 weeks
Exclusion Criteria:
Not healthy (ie. fever or other conditions which caused subjects were not able to be examined)
Secondary infection has been found ( yellow crusts, pus, dirty skin lesion, bullae, or systemic symptoms ie. fever)
Facility Information:
Facility Name
Departemen Dermatologi dan Venereologi Fakultas Kedokteran Universitas Indonesia
City
Jakarta
State/Province
Jakarta Pusat
ZIP/Postal Code
10430
Country
Indonesia
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Efficacy and Side Effects of Blacksoap® as Adjuvant Therapy of Scabies
We'll reach out to this number within 24 hrs